Wow! Thanks for sharing, Jack. It sounds like the reality of the situation with L is as many of us feared. No resolution in sight. Wouldn't it be something if they simply stopped the L trial after all of these years? Maybe the IA results were so dismal that they stopped screening new patients to buy as much time as possible for Direct to show something positive. Even Les is now trying to temper expectations, yikes!!
Well, I guess maybe there won't be a rush to get back in the stock during January. At least not until the investigation is wrapped up, which is March at the earliest. If the 12m really is for the launch Direct phase 2, I am really confused about the small amount they financed. If they are planning to conduct multiple large cohorts in parallel, it will take many multiples of the amount they received...Hmm, not passing the sniff test in my book. Happy New Year!!